It's A Deal: Pierre Fabre Group & Abbott Healthcare Renew Partnership | LATF USA NEWS
Fondation Pierre Fabre: Improving healthcare in the Global South
Pierre Fabre to Commercialize and Distribute the First Approved Allogeneic T-cell Immunotherapy in Europe Following Transfer of the European Commission Marketing Authorization of EBVALLO™ (tabelecleucel) | Business Wire
Pierre Fabre | A French pharmaceutical and dermocosmetics group
CareOS - The first smart Health & Beauty platform for the bathroom.